The Service Contract Agreement was signed between the Drug Regulatory Authority(DRA) and the National Drug Testing Laboratory (NDTL), Royal Centre for Disease Control (RCDC) on 13 December 2018. During the signing, both the Parties acknowledged the importance of working together towards ensuring the quality of medicinal products in the country. The Parties agreed that the event would symbolize the strong relationship and willingness of collaboration between the two agencies. The DRA expressed its strong commitment and hopes for further strengthening collaboration with the NDTL, RCDC and other stakeholders in future.